MicroRNA suppresses prostate cancer stem cells and metastasis — UT MD Anderson preclinical research boosts case for new drug approach – A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells, revealed by researchers.
Advanced Cell Technology Receives FDA Clearance For the First Clinical Trial Using Embryonic Stem Cells to Treat Macular Degeneration — FDA Lifts Clinical Hold; Company to Commence a Phase I/II Clinical Trial at Multiple Centers – Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC) announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt’s Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world.
Physical fitness curbs frequency and severity of colds — Upper respiratory tract infection is reduced in physically fit and active adults – People who are physically fit and active have fewer and milder colds, indicates research published online in the British Journal of Sports Medicine.
Geron Initiates Clinical Trial of Human Embryonic Stem Cell-Based Therapy — First Patient Treated at Shepherd Center in Atlanta – Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in the company’s clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.
Stem cells shape up to their surroundings – Many scientists aspire to take control over the stem cell differentiation process, so that we can grow organs and implants perfectly matched to each patient in the future.
US can continue stem cell research – An appeals court in US allowed the government to resume funding human embryonic stem cell research while the court reviews whether it violates a ban by Congress on spending taxpayer money for experiments.
American Association for Cancer Research (AACR) supports NIH stem cell research – The American Association for Cancer Research (AACR), the world’s oldest and largest cancer research organization, reiterates its support for the responsible conduct of human embryonic stem cell research that, up until this week, was funded by the National Institutes of Health (NIH) and expresses concern that the recent Federal District Court injunction to block federal funding for human embryonic stem cell research is a setback for scientific discovery.
Stanford stem cell scientist leads effort to prevent fraudulent treatment – Leading stem cell researchers from institutions around the world are issuing warnings about unproven stem cell therapies being marketed on the Internet and have launched a website to educate and protect patients seeking such treatments.
Do we clamp the umbilical cord too soon? — USF researchers: Early clamping may interrupt humankind’s first ‘natural stem cell transplant’ – The timing of umbilical cord clamping at birth should be delayed just a few minutes longer, suggest researchers at the University of South Florida’s Center of Excellence for Aging and Brain Repair.
Aiming to cure deafness, Stanford scientists first to create functional inner-ear cells – Researchers have found a way to coax embryonic stem cells as well as reprogrammed adult cells to develop into sensory cells that normally reside in the mammalian inner ear. Those mechanosensitive sensory hair cells are the linchpin of hearing and balance.
Broccoli component limits breast cancer stem cells, U-M study finds — Research in mice, cells suggests possible prevention, treatment strategy – A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells — the small number of cells that fuel a tumor’s growth — according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
University of Michigan scientists discover bone marrow can harbor HIV-infected cells — Targeting these reservoirs of latent cells may open door to new treatments – University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
